Resect AI raises $25M to build 'Polygraph' for enterprise LLM hallucination control.
7
What is the Viqus Verdict?
We evaluate each news story based on its real impact versus its media hype to offer a clear and objective perspective.
AI Analysis:
Moderate hype surrounding a niche technical solution (hallucination auditing), but the high Impact Score reflects that establishing enterprise-grade trust and compliance is a genuinely structural shift for B2B AI adoption.
Article Summary
Seattle-based Resect AI announced its successful close of a $25 million funding round aimed at addressing the critical issue of AI hallucinations (confabulations) within enterprise models. The company aims to provide an accountability layer, promising to bring transparency to the previously 'black box' nature of LLMs. Resect plans to develop the NeuroWave Product Suite, described as a 'polygraph for neural networks,' which will observe, detect, interpret, and modify model behavior at runtime. While acknowledging that many proprietary models are challenging to audit, Resect claims to have developed proprietary methods to understand model decision-making processes and surgically fix failures. The company also released two open-source models (0.6B and 8B parameters) on HuggingFace, demonstrating improved factuality scores against the Qwen3 architecture.Key Points
- Resect AI raised $25 million to create enterprise tools specifically designed to minimize AI hallucination.
- The core product, NeuroWave, will function as an audit suite to provide transparency and control over the internal decision-making processes of LLMs.
- The firm's approach shifts focus from building larger models to building verifiable toolkits that can be applied to existing open-source architectures like Llama and DeepSeek.

